Skip to main content

Table 1 Patient demographic and operative characteristics for the entire cohort and for those with Beck Depression Inventory data (n = 320). The patients are categorized as having depression based on a Beck Depression Inventory score > 13 before surgery. The p-value listed is for comparison of each variable between patients without and with depression at the time of surgery

From: Postoperative but not preoperative depression is associated with cognitive impairment after cardiac surgery: exploratory analysis of data from a randomized trial

 

Total Cohort

n = 460

No Depression

n = 270

Depression

N = 50

P-Valueb

Standardized Difference

Age (mean (SD))

70.42 (7.66)

70.62 (7.54)

68.74 (8.45)

0.113

0.235

Female (%)a

129 (28.1)

71 (26.4)

18 (36.0)

0.172

0.208

Race (%)a

   

0.283

0.445

  White

373 (81.3)

224 (83.3)

37 (74.0)

  African American

52 (11.3)

25 (9.3)

11 (22.0)

  Asian-Oriental

4 (0.9)

3 (1.1)

0 (0.0)

  Asian-Subcontinent

4 (0.9)

3 (1.1)

0 (0.0)

  Hispanic

5 (1.1)

3 (1.1)

0 (0.0)

  Multiple

2 (0.4)

1 0.4)

0 (0.0)

  Other

19 (4.1)

10 (3.7)

2 (4.0)

BMI > 30 (%)

192 (41.7)

106 (39.3)

20 (40.0)

0.999

0.015

Diabetes (%)a

209 (46.1)

111 (41.3)

26 (54.2)

0.114

0.261

Hypertension (%)

420 (91.3)

240 (88.9)

49 (98.0)

0.064

0.375

Prior stroke (%)a

44 (10.0)

20 (7.7)

9 (19.1)

0.025

0.342

Prior myocardial infarction (%)a

139 (30.5)

75 (28.0)

15 (30.0)

0.864

0.044

Atrial fibrillation (%)a

102 (22.4)

62 (23.0)

9 (18.0)

0.579

0.125

Chronic obstructive pulmonary disease (%)a

52 (11.6)

28 (10.6)

11 (22.9)

0.030

0.333

Current tobacco use (%)a

46 (10.2)

25 (9.3)

6 (12.5)

0.441

0.102

Years of attained education (median [IQR])

14.00 [12.00, 17.00]

15.00 [12.00, 17.00]

12.00 [12.00, 16.75]

0.027

0.403

Anti-depressant drug usage (%)

62 (13.4)

33 (12.2)

10 (20)

0.172

0.213

Surgical procedure (%)

   

0.545

0.495

  CABG

226 (49.1)

122 (45.2)

26 (52.0)

  CABG/AVR

61 (13.3)

36 (13.3)

9 (18.0)

  CABG/MVR

15 (3.3)

8 (3.0)

2 (4.0)

  CABG/AVR/MVR

89 (19.3)

55 (20.4)

11 (22.0)

  AVR

41 (8.9)

30 (11.1)

1 (2.0)

  MVR

6 (1.3)

5 (1.9)

0 (0.0)

  AVR/MVR

14 (3.0)

10 (3.7)

1 (2.0)

  Aortic root replacement

4 (0.9)

2 (0.7)

0 (0.0)

  CABG/Aortic Root Replacement

1 0.2)

0 (0.0)

0 (0.0)

  TVR

3 (0.7)

2 (0.7)

0 (0.0)

Surgical Parameters

  Minutes of cardiopulmonary bypass (median [interquartile range])

104.0 [81.2, 140.7]

107.0 [82.0, 142.0]

103.0 [84.0, 132.0]

0.934

0.078

  Minutes of aortic cross-clamping (median [interquartile range])

71.0 [54.0, 93.5]

73.0 [56.0, 94.0]

72.5 [55.0, 94.7]

0.959

0.001

  Impaired cerebral autoregulation during cardiopulmonary bypass (%)

130 (28.7)

74 (27.9)

8 (16.7)

0.111

0.273

  MAP (mmHg) at the lower limit of autoregulation (median [interquartile range])

65.0 [60.0, 75.0]

70.0 [60.0, 75.0]

65.0 [60.0, 70.0]

0.797

0.070

  Area under the curve that MAP was ≤ the lower limit of cerebral autoregulation (median [interquartile range] mmHg x hr)1

6.75 [2.41, 14.78]

7.45 [2.66, 16.20]

4.60 [1.66, 10.24]

0.059

0.379

  1. CABG coronary artery bypass graft surgery, AVR aortic valve replacement, MVR mitral valve repair or replacement, TVR tricuspid valve replacement;
  2. aMissing excluded from summaries and denominators (age [n = 1], sex [n = 1]; race [n = 1]; diabetes [n = 3]; prior stroke [n = 12]; prior myocardial infarction [n = 2]; atrial fibrillation [n = 1]; chronic obstructive pulmonary disease [n = 9]; current tobacco use [n = 4]; years of attained education [n = 44]; minutes of cardiopulmonary bypass [n = 2]; impaired cerebral autoregulation [n = 7]; MAP [n = 5]; area under the curve [n = 5]);
  3. bP-value from complete cases analysis via fisher’s exact for categorical variables, t-tests for normal continuous variables, and Wilcoxon rank sum tests for non-normal continuous variables